Manning & Napier Disciplined Value S holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Manning & Napier Disciplined Value Series Class S MDFSX
- NAV / 1-Day Return 9.05 / +0.11 %
- Total Assets 131.7M
-
Adj. Expense Ratio
0.780%
- Expense Ratio 0.780%
- Distribution Fee Level Average
- Share Class Type No Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 2,000
- Status Open
- TTM Yield 1.71%
- Turnover 49%
USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 12:35 AM GMT+0
Morningstar’s Analysis MDFSX
Will MDFSX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Merck & Co Inc | 4.24 | 6M | Healthcare |
UnitedHealth Group Inc | 3.85 | 5M | Healthcare |
Citigroup Inc | 3.59 | 5M | Financial Services |
ExxonMobil Holdings Corp | 2.71 | 4M | Energy |
Qualcomm Inc | 2.61 | 3M | Technology |
Wells Fargo & Co | 2.52 | 3M | Financial Services |
Gilead Sciences Inc | 2.39 | 3M | Healthcare |
ConocoPhillips | 2.12 | 3M | Energy |
Progressive Corp | 2.08 | 3M | Financial Services |
Bristol-Myers Squibb Co | 2.07 | 3M | Healthcare |